Sort   by:  
 Page size 
Unknown[Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19].
Not available
S-EPMC8570981 | biostudies-literature
UnknownExecutive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19.
Not available
S-EPMC8853860 | biostudies-literature
UnknownCombination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study.
Not available
S-EPMC7908857 | biostudies-literature
UnknownCOVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study.
Not available
S-EPMC11612230 | biostudies-literature
UnknownAnalysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19.
Not available
S-EPMC8783837 | biostudies-literature
UnknownDesign and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study.
Not available
S-EPMC2779817 | biostudies-literature
UnknownEpidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Not available
S-EPMC9543728 | biostudies-literature
UnknownAnti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study.
Not available
S-EPMC9384616 | biostudies-literature
UnknownHCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients.
Not available
S-EPMC8010945 | biostudies-literature
UnknownRapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.
Not available
S-EPMC6704069 | biostudies-literature
Sort   by:  
 Page size